Does GAO-22-105357's primary PDF confirm the $8.0B/$5.0B/$2.6B OT consortia technology-area breakdown (FY2019–2021)?

other-transactions-authoritygaodefense-fundingverificationantigravityaawsap

question-verify-gao-22-105357-ot-consortia-breakdown-primary asked whether a direct read of GAO-22-105357's own PDF — rather than trade-press summaries of it — would confirm the $8.0 billion (medical defense) / $5.0 billion (armaments) / $2.6 billion (aviation and missiles) figures that claim-gao-2022-ot-consortia-breakdown-shows-conventional-categories-not-fringe-physics carries as [unverified-quant]. gao.gov's own hosting of the PDF, product page, and highlights page all 403'd to every tool tried this session (extract_pdf, archive_page, WebFetch), matching the known-blocked entry in sources.md. The Wayback Machine held a clean, complete snapshot of the PDF (75 pages, tls:verified), retrieved via the id_ raw-bytes modifier. The answer is yes: the primary report states the same three figures, in the same wording trade press paraphrased, in both its Highlights section and its body letter.

Claim: GAO-22-105357's primary PDF confirms, in GAO's own words, that medical defense, armaments, and aviation-and-missiles consortia received $8.0B/$5.0B/$2.6B respectively from DOD OT obligations, FY2019–2021

verifies: question-verify-gao-22-105357-ot-consortia-breakdown-primary

A direct read of GAO-22-105357 ("Other Transaction Agreements: DOD Can Improve Planning for Consortia Awards," September 2022) confirms the figure at the primary. The Highlights section states: "GAO analyzed other sources of OTA data, including from industry, and found that from fiscal years 2019 through 2021, the top three consortia—medical defense, armaments, and aviation and missiles—received obligations of $8.0 billion, $5.0 billion, and $2.6 billion, respectively, from DOD." The body letter restates the same figures with the methodology behind them: GAO compiled data from the Federal Procurement Data System, DOD, Consortium Management Organizations (CMOs), and public sources — because DOD itself had no systematic way to track obligations by consortium — covering $24.3 billion in consortia-based Other Transaction obligations across 12 CMOs and 28 consortia. This resolves the [unverified-quant] flag: the $8.0B/$5.0B/$2.6B figures are not a trade-press paraphrase but GAO's own stated finding, independently legible in two separate passages of the same document (Highlights and Letter).

Claim: GAO's full technology-area table (Figure 5) extends the top-three figures with two more large, conventional categories — space ($1.3B) and command/control/communications ($1.0B) — and eight smaller consortia, none of them a fringe-physics or exotic-propulsion category

verifies: question-verify-gao-22-105357-ot-consortia-breakdown-primary

The same body-letter passage that confirms the top three figures continues: "...$1.3 billion in space; and $1.0 billion in command, control, and communications consortia (see fig. 5)." Figure 5's accessible data table (p. 22–23) itemizes the remainder of the $24.3 billion across eight smaller named technology-area consortia managed by the same four CMOs: countering weapons of mass destruction ($0.765B), spectrum ($0.593B), medical technology ($0.535B, distinct from the $8.0B medical defense consortium), undersea technology ($0.220B), information warfare ($0.203B), naval surface ($0.087B), shipbuilding research ($0.035B), and vertical lift ($0.010B) — plus "8 other consortium management organizations" accounting for a further $1.3 billion GAO could not break out by individual consortium. Every named category in the full table, largest to smallest, is a conventional area of defense acquisition; none references antigravity, exotic propulsion, or any comparable fringe-physics domain. This extends, at the primary, the qualitative conclusion claim-gao-2022-ot-consortia-breakdown-shows-conventional-categories-not-fringe-physics already drew from trade-press coverage of the top three alone.

Claim: GAO distinguishes its $8.0B medical-defense figure (FY2019–2021, this report) from a separate $7.2B figure in its own earlier July 2021 report (March 2020–March 2021) — the two are not the same number restated, but two different measurements over two different windows

GAO-22-105357 footnotes its $8.0B medical-defense figure with a pointer to its own prior work: "In July 2021, we found that from March 2020 through March 2021, DOD obligated $7.2 billion on OTAs awarded to members of a medical defense consortium mostly for vaccine development and manufacturing. For more information on COVID-19 OTAs awarded to consortia, see GAO-21-501." The $8.0B figure in this report covers three full fiscal years (FY2019–2021) and is explicitly described as "primarily for COVID-19 vaccine development" — a broader population over a longer window than the $7.2B figure, which covers roughly one year (March 2020–March 2021) and was reported in a different, earlier GAO product (GAO-21-501, not independently fetched this session). The two figures are compatible, not contradictory, once the different reports and windows are distinguished; an AI-generated search summary consulted during this session's research had flagged this as a "conflicting reading" between sources, which the primary text itself resolves.

Further leads

• GAO-21-501 (July 26, 2021), GAO's own prior COVID-19 OTA report, is cited repeatedly inside GAO-22-105357 (footnotes 2, 23, 28, 32) and inside DODIG-2022-127 for a related finding — that the $7.2B consortium figure was distributed almost entirely to five pharmaceutical companies — but has not been independently fetched and read in this vault; it would be the most direct corroboration or complication of Claim 3 above.
• GAO-22-105357's Table 4 ("Selected Department of Defense Consortia and Associated Technology Areas," p. 43) and Appendix II ("List of Consortia that Received Department of Defense Other Transaction Agreement Awards, Fiscal Years 2019–2021," p. 58) were not read in full this session; either could be checked against claim-ac-gravity-aawsap-not-same-funding-mechanism-nor-found-in-watchdog-material for a consortium-level (not just technology-area-level) cross-check of fringe-physics-adjacent funding.
• GovConWire's write-up of the same report (govconwire.com/?p=301513), cited by name in the prior capture but not independently fetched, was not re-checked this session now that the primary itself is in hand.
• Figure 5's text sentence rounds the space category to "$1.3 billion" while the accessible table's line items for space (ATI: $1.1B; NSTXL: $0.166B) sum to roughly $1.27B — a minor rounding/presentation note, not a substantive discrepancy.

Entity candidates

• GAO-21-501 ("COVID-19 Contracting: Actions Needed to Enhance Transparency and Oversight of Selected Awards," July 26, 2021) — document — GAO's own earlier report, repeatedly cited inside GAO-22-105357 as the source of the related $7.2B figure and prior recommendations; the earlier primary record this report's medical-defense figure is implicitly measured against and distinguished from.
• DODIG-2021-077 (DoD Inspector General, "Audit of Other Transactions Awarded Through Consortiums," April 21, 2021) — document — cited in GAO-22-105357's background as a parallel prior finding on consortia-based OTAs; an earlier, independent oversight product covering an overlapping population.
• Advanced Technology International (ATI) — concept/organization — the Consortium Management Organization managing $19.1 billion of the $24.3 billion total (roughly 79 percent), including all three top-line technology areas (medical defense, armaments, aviation and missiles); the dominant real-world actor behind the headline figures, not yet an entity page in this vault.
• Marie A. Mak — person — GAO Director, Contracting and National Security Acquisitions, named as GAO's point of contact on GAO-22-105357's Highlights page.
• Federal Procurement Data System (FPDS) — concept — the DoD-wide procurement tracking system GAO found could not, on its own, distinguish consortium-based OTAs or track obligations by consortium; the system-level gap underlying both this report and claim-crs-gao-found-dod-lacks-systematic-ot-funding-data-by-subject-area.